SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-23-014992
Filing Date
2023-07-18
Accepted
2023-07-18 16:13:31
Documents
2
Period of Report
2023-07-17

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1613
2 POA exhibit24-1.txt EX-24.1 2596
  Complete submission text file 0001062993-23-014992.txt   5756
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2600 KELLY RD WARRINGTON PA 18976
Business Address
Clayton Russell (Reporting) CIK: 0001530072 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 231094396